U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06805565) titled 'A Study of ONO-1110 in Patients With Social Anxiety Disorder' on Jan. 28.
Brief Summary: To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Social Anxiety Disorder
Study Start Date: Jan. 31
Study Type: INTERVENTIONAL
Condition:
Social Anxiety Disorder (SAD)
Intervention:
DRUG: ONO-1110
ONO-1110 tablets once a day
DRUG: Placebo
Placebo tablets once daily
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Ono Pharmaceutical Co. Ltd
Published by HT Digital Content Services with permission from Health Daily Digest....